PharmCon freeCE’s Post

Great news! GSK (LSE/NYSE: GSK) has made AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) available at major retail pharmacies in the US. The Advisory Committee on Immunization Practices (ACIP) recommended a single dose of this vaccine for individuals aged 60 and older, empowering patients to decide with their healthcare providers if it's suitable for them. AREXVY is designed to prevent RSV-lower respiratory tract disease in this age group. For Medicare Part D patients, there are no out-of-pocket expenses under the Inflation Reduction Act. Commercially insured patients may have coverage with no cost when administered in-network, so it's advisable to check with your doctor or pharmacist. RSV is a significant concern for older adults, and this vaccine offers hope in reducing its impact on public health. #Healthcare #Vaccine #RSV #GSK #VaccinesSaveLives

Vaccine-preventable diseases pose a significant public health burden, yet even in the most developed regions adult vaccine spend is less than 2% of total pharmaceutical expenditure. Adult immunization coverage is sub-optimal and has further declined since the pandemic, even though improving adult vaccination rates are critical to: ✔️ reduce disease-associated outcomes  ✔️ improve health and prevent premature death ✔️ reduce healthcare costs ✔️ relieve pressure on hospitals To find out more about the current Trends in Global Adult Vaccination: Impact of COVID-19 download IQVIA Institute’s report https://bit.ly/45MzkrH #vaccines #COVID19 #adultvaccinations #pharmaceutical

New Respiratory Syncytial Virus (RSV) Vaccine Recommendation for Older Adults Join PharmScript, LLC. on Wednesday, July 19, from 2:00-3:00 pm EDT. Pamela Smith, PharmD, with Pfizer, will present the webinar. Register today: https://bit.ly/rsvvaccine Learning objectives: 1) Describe the burden of disease for respiratory syncytial virus (RSV) 2) Review the Advisory Committee on Immunization Practices (ACIP) Meeting June 21, 2023, recommendations for RSV Vaccines 3) Provide an overview of bivalent RSV Prefusion F Vaccine (RSVpreF), including safety and efficacy in adults 60 years of age and older #pharmscript #nurses #administrators #infectioncontrol #medicaldirectors #education #webinar #learning #vaccines

We are pleased to share that the peer reviewed quarterly Journal for Pharmacovigilance and Drug Research have recently published an article titled ‘Knowledge, attitude, and practices regarding reporting of Adverse Events following immunization (AEFI) among healthcare professionals’ which was co-authored by our very own Dr. Akash Gadgade. Vaccines enhance immunity, yet AEFI challenge public trust and immunization coverage by impacting safety perceptions. Following a cross-sectional study this paper evaluates AEFI reporting awareness post-routine immunization. To view the article in full, please visit: https://lnkd.in/gRNf5y44 #JPADR #Vaccines #Immunizations #AEFI #DrugSafety #PV #pharmacovigilance

The latest episode of "The Pharmacists Are In" is now available! In this episode, John Papastergiou is joined by Ajit Johal to explore the evolving role of pharmacists in vaccination services. They delve into the importance of vaccinations like HPV and flu, discussing how pharmacists are ideally positioned to enhance community health through expanded vaccination programs. Click below or look for "The Pharmacists Are In" on your favourite podcast platforms! #hpv #flu #vaccination #pharmacy #pharmacist #podcast #thepharmacistsarein

Drugmakers anticipate putting a dent soon in the country's shortage of respiratory syncytial virus (RSV) vaccine, with 230,000 more infant doses being readied for distribution by mid-January. Pediatricians, hospitals, and parents have struggled for months to get protection for their babies due to what manufacturer Sanofi has characterized as "unprecedented demand" for the new immunization that was only approved late this summer. By mid-October, manufacturers had already depleted their supply of 100-mg doses, prompting CDC to recommend prioritizing vaccination of high-risk infants. Despite the release of 77,000 additional doses in November, the shortage has persisted as RSV nears its peak. https://lnkd.in/e4_mipHs #rsv #pharmacyinthenews #vaccines

Pharmacist Immunization Interventions Boost Public Vaccination Rate, Study Finds Pharmacists play a significant role in improving immunization rates, with pharmacist interventions increasing immunization uptake by up to 51%. However, the impact of pharmacist immunizers varied, suggesting that the depth of their engagement could influence vaccination rates. More research is needed to understand the role of pharmacists in enhancing immunization rates. For more details please click the link! https://lnkd.in/dHcrSBPY #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical

Exciting updates in the medical coding world! 🩺 Just in: New CPT codes (91318-91322) for Moderna and Pfizer's COVID-19 vaccines, streamlining reporting. 🌐 Also, check out the latest RSV immunization codes (90380-90381) for enhanced tracking and reporting. 💉 Stay informed on healthcare changes! #CPTcodes #HealthcareUpdates #MedicalCoding #COVID19Vaccines #RSVImmunization #HealthTech #linkedinupdate

🌟 Vaccine Reporting: Key Codes for RCM Pros For accurate reimbursement, it's vital to know the pediatric immunization codes 90460 & 90461. - 90460: For the first vaccine component, includes counseling, for patients under 18. - 90461: Add-on for each extra component, reported with 90460. 👩⚕ Coding Tip: Without counseling, use 90471-90474 instead. Remember to bill vaccines separately. EXAMPLE An 11-year-old gets HPV and Tdap with counseling. - Bill 90651, 90715 for vaccines. - Use 90460*2 for each first component and 90461*2 for additional ones (90715 shows 3 components., added the first component in 90460 and the other 2 in 90461) Above all, if in doubt, check your SOPs, guidelines, AI tools, and verify till you're 100% sure. Accurate coding is crucial for reimbursement and public health. Stay updated on best practices! 💪💉 #Healthcare #revenuecyclemanagement #medicalbilling

To kick off World Immunization Week, we’re sharing a recent op-ed co-authored by Walgreens VP of Pharmacy Services Anita Patel. In it, Patel and her colleagues argue that making permanent the authority pharmacists were given during the pandemic will increase immunization rates and save lives. Read the full op-ed in Governing at the link below. #WorldImmunizationWeek #Pharmacy #Healthcare #Vaccines